\r\n![\"Bio-Rad](\"https:\/\/clixtrac.com\/banner\/311442.jpg\" "\\"Bio-Rad")
<\/a>\r\n<\/p>\n<\/div><\/section><\/div>
![\"\"](\"https:\/\/clixtrac.com\/banner\/283809.png\" "\\"\\"")
<\/a>\r\n<\/div><\/p>\n<\/div><\/section>\n
FUJIFILM Irvine Scientific launches HEK293 feed, specifically designed for viral vector production<\/h1>Product News<\/a> <\/span><\/span><\/header>\n<\/div><\/section>
\nFUJIFILM Irvine Scientific, a world leader in the development and manufacture of serumfree and chemically defined cell culture media for bioproduction and cell therapy manu-facturing, has introduced its BalanCD HEK293 Viral Feed. The chemically defined, nutrient-based HEK293-specific feed medium is designed to boost adeno-associated viral vector (AAV) production for gene therapy applications and viral vector-based vaccines.<\/strong><\/p>\n
<\/p>\n
Numerous gene therapies have received FDA approval and as more viral vector-based vaccines and gene therapies move into commercialization, the demand for large-scale, efficient viral vector manufacturing is increasing. For manufacturers, it is imperative to boost viral vector production to meet supply demands for vaccine and gene therapy manufacture.<\/p>\n
BalanCD HEK293 Viral Feed is optimized to deliver high titers and improve viral packaging efficiency by up to 67% compared to basal control without viral-specific feed for increased production efficiency. It is chemically defined and formulated to deliver consistent performance while increasing viral vector production in HEK293 cells grown in suspension and at scale.<\/p>\n<\/div><\/section>
\n
![\"\"](\"https:\/\/clinlabint.com\/wp-content\/uploads\/sites\/2\/2023\/03\/fujifilm-balansCD.png\" "\\"fujifilm")
<\/div><\/div><\/div>
\n\u201cViral vector manufacturing must evolve rapidly to support increased numbers of gene therapies and viral vector-based vaccines being developed and commercialized. We developed BalanCD HEK293 Viral Feed specifically to increase yields and help manufacturers maximize production, and lower cost of goods related to viral vector-based drug programmes,\u201d said Erik Vaessen, chief business officer, FUJIFILM Irvine Scientific.<\/p>\n
BalanCD HEK293 Viral Feed is GMP manufactured using raw materials sourced using a strict raw material and supply chain programme to ensure continuity of supply and lot-to-lot reliability for HEK293-specific applications. It is available in a 500 mL liquid format and made-to-order powder format, and may be used with a wide range of basal growth media.<\/p>\n
For more information, visit: htt<\/em>ps:\/\/www.irvinesci.co<\/em>m<\/em><\/a>.<\/em><\/p>\n
Digital issue: Please click here<\/a> for more information<\/p>\n<\/div><\/section>
\n
\nShare this<\/h5>- Share by Mail<\/span><\/a><\/li><\/ul><\/div><\/div><\/p><\/div>
\r\n![\"Forum](\"https:\/\/clixtrac.com\/banner\/318671.jpg\" "\\"Forum")
<\/a>\r\n<\/div><\/p>\n<\/div><\/section><\/div>\n","protected":false},"excerpt":{"rendered":"FUJIFILM Irvine Scientific, a world leader in the development and manufacture of serumfree and chemically defined cell culture media for bioproduction and cell therapy manu-facturing, has introduced its BalanCD HEK293 Viral Feed. The chemically defined, nutrient-based HEK293-specific feed medium is designed to boost adeno-associated viral vector (AAV) production for gene therapy applications and viral vector-based […]<\/p>\n","protected":false},"author":3,"featured_media":19133,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_monsterinsights_skip_tracking":false,"_monsterinsights_sitenote_active":false,"_monsterinsights_sitenote_note":"","_monsterinsights_sitenote_category":0,"footnotes":""},"categories":[39],"tags":[],"class_list":["post-19132","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-product-news"],"_links":{"self":[{"href":"https:\/\/clinlabint.com\/wp-json\/wp\/v2\/posts\/19132","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/clinlabint.com\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/clinlabint.com\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/clinlabint.com\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/clinlabint.com\/wp-json\/wp\/v2\/comments?post=19132"}],"version-history":[{"count":2,"href":"https:\/\/clinlabint.com\/wp-json\/wp\/v2\/posts\/19132\/revisions"}],"predecessor-version":[{"id":19135,"href":"https:\/\/clinlabint.com\/wp-json\/wp\/v2\/posts\/19132\/revisions\/19135"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/clinlabint.com\/wp-json\/wp\/v2\/media\/19133"}],"wp:attachment":[{"href":"https:\/\/clinlabint.com\/wp-json\/wp\/v2\/media?parent=19132"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/clinlabint.com\/wp-json\/wp\/v2\/categories?post=19132"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/clinlabint.com\/wp-json\/wp\/v2\/tags?post=19132"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}
FUJIFILM Irvine Scientific, a world leader in the development and manufacture of serumfree and chemically defined cell culture media for bioproduction and cell therapy manu-facturing, has introduced its BalanCD HEK293 Viral Feed. The chemically defined, nutrient-based HEK293-specific feed medium is designed to boost adeno-associated viral vector (AAV) production for gene therapy applications and viral vector-based vaccines.<\/strong><\/p>\n
<\/p>\n
Numerous gene therapies have received FDA approval and as more viral vector-based vaccines and gene therapies move into commercialization, the demand for large-scale, efficient viral vector manufacturing is increasing. For manufacturers, it is imperative to boost viral vector production to meet supply demands for vaccine and gene therapy manufacture.<\/p>\n
BalanCD HEK293 Viral Feed is optimized to deliver high titers and improve viral packaging efficiency by up to 67% compared to basal control without viral-specific feed for increased production efficiency. It is chemically defined and formulated to deliver consistent performance while increasing viral vector production in HEK293 cells grown in suspension and at scale.<\/p>\n<\/div><\/section>
\n
<\/div><\/div><\/div>\n
\u201cViral vector manufacturing must evolve rapidly to support increased numbers of gene therapies and viral vector-based vaccines being developed and commercialized. We developed BalanCD HEK293 Viral Feed specifically to increase yields and help manufacturers maximize production, and lower cost of goods related to viral vector-based drug programmes,\u201d said Erik Vaessen, chief business officer, FUJIFILM Irvine Scientific.<\/p>\n
BalanCD HEK293 Viral Feed is GMP manufactured using raw materials sourced using a strict raw material and supply chain programme to ensure continuity of supply and lot-to-lot reliability for HEK293-specific applications. It is available in a 500 mL liquid format and made-to-order powder format, and may be used with a wide range of basal growth media.<\/p>\n
For more information, visit: htt<\/em>ps:\/\/www.irvinesci.co<\/em>m<\/em><\/a>.<\/em><\/p>\n
Digital issue: Please click here<\/a> for more information<\/p>\n<\/div><\/section>
\n
Share this<\/h5>- Share by Mail<\/span><\/a><\/li><\/ul><\/div><\/div><\/p><\/div>
\r\n<\/a>\r\n<\/div><\/p>\n<\/div><\/section><\/div>\n","protected":false},"excerpt":{"rendered":"FUJIFILM Irvine Scientific, a world leader in the development and manufacture of serumfree and chemically defined cell culture media for bioproduction and cell therapy manu-facturing, has introduced its BalanCD HEK293 Viral Feed. The chemically defined, nutrient-based HEK293-specific feed medium is designed to boost adeno-associated viral vector (AAV) production for gene therapy applications and viral vector-based […]<\/p>\n","protected":false},"author":3,"featured_media":19133,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_monsterinsights_skip_tracking":false,"_monsterinsights_sitenote_active":false,"_monsterinsights_sitenote_note":"","_monsterinsights_sitenote_category":0,"footnotes":""},"categories":[39],"tags":[],"class_list":["post-19132","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-product-news"],"_links":{"self":[{"href":"https:\/\/clinlabint.com\/wp-json\/wp\/v2\/posts\/19132","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/clinlabint.com\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/clinlabint.com\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/clinlabint.com\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/clinlabint.com\/wp-json\/wp\/v2\/comments?post=19132"}],"version-history":[{"count":2,"href":"https:\/\/clinlabint.com\/wp-json\/wp\/v2\/posts\/19132\/revisions"}],"predecessor-version":[{"id":19135,"href":"https:\/\/clinlabint.com\/wp-json\/wp\/v2\/posts\/19132\/revisions\/19135"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/clinlabint.com\/wp-json\/wp\/v2\/media\/19133"}],"wp:attachment":[{"href":"https:\/\/clinlabint.com\/wp-json\/wp\/v2\/media?parent=19132"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/clinlabint.com\/wp-json\/wp\/v2\/categories?post=19132"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/clinlabint.com\/wp-json\/wp\/v2\/tags?post=19132"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}
<\/a>\r\n<\/div><\/p>\n<\/div><\/section><\/div>\n","protected":false},"excerpt":{"rendered":"FUJIFILM Irvine Scientific, a world leader in the development and manufacture of serumfree and chemically defined cell culture media for bioproduction and cell therapy manu-facturing, has introduced its BalanCD HEK293 Viral Feed. The chemically defined, nutrient-based HEK293-specific feed medium is designed to boost adeno-associated viral vector (AAV) production for gene therapy applications and viral vector-based […]<\/p>\n","protected":false},"author":3,"featured_media":19133,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_monsterinsights_skip_tracking":false,"_monsterinsights_sitenote_active":false,"_monsterinsights_sitenote_note":"","_monsterinsights_sitenote_category":0,"footnotes":""},"categories":[39],"tags":[],"class_list":["post-19132","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-product-news"],"_links":{"self":[{"href":"https:\/\/clinlabint.com\/wp-json\/wp\/v2\/posts\/19132","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/clinlabint.com\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/clinlabint.com\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/clinlabint.com\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/clinlabint.com\/wp-json\/wp\/v2\/comments?post=19132"}],"version-history":[{"count":2,"href":"https:\/\/clinlabint.com\/wp-json\/wp\/v2\/posts\/19132\/revisions"}],"predecessor-version":[{"id":19135,"href":"https:\/\/clinlabint.com\/wp-json\/wp\/v2\/posts\/19132\/revisions\/19135"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/clinlabint.com\/wp-json\/wp\/v2\/media\/19133"}],"wp:attachment":[{"href":"https:\/\/clinlabint.com\/wp-json\/wp\/v2\/media?parent=19132"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/clinlabint.com\/wp-json\/wp\/v2\/categories?post=19132"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/clinlabint.com\/wp-json\/wp\/v2\/tags?post=19132"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}